TY - JOUR
T1 - The interplay of ethics and genetic technologies in balancing the social valuation of the human genome in UNESCO declarations.
AU - Gaydarska, H
AU - Takashima, K
AU - Shahrier, S
AU - Raz, Aviad
AU - Minari, Jusaku
PY - 2024/2/15
Y1 - 2024/2/15
N2 - This study investigates changes in the social valuation of the human genome over the more than 30 years since the establishment of the Human Genome Project. It offers a descriptive sociological analysis of the three waves of this valuation, mainly by considering three key UNESCO declarations and a relevant report. These waves represent a shifting balance between collectivism and individualism, starting with a broadly constructed valuation of the human genome as common human heritage and moving toward a valuation of dynamic applications within various social and medical contexts (e.g., personalized genomic medicine and genome editing). We seek to broaden the analytical perspective by examining how the declarations' ethical foci are framed within the context of rapidly evolving genetic technologies and their social applications. We conclude by discussing continuity and change in value balancing vis-à-vis changing genomic technologies.
AB - This study investigates changes in the social valuation of the human genome over the more than 30 years since the establishment of the Human Genome Project. It offers a descriptive sociological analysis of the three waves of this valuation, mainly by considering three key UNESCO declarations and a relevant report. These waves represent a shifting balance between collectivism and individualism, starting with a broadly constructed valuation of the human genome as common human heritage and moving toward a valuation of dynamic applications within various social and medical contexts (e.g., personalized genomic medicine and genome editing). We seek to broaden the analytical perspective by examining how the declarations' ethical foci are framed within the context of rapidly evolving genetic technologies and their social applications. We conclude by discussing continuity and change in value balancing vis-à-vis changing genomic technologies.
UR - https://doi.org/10.1038/s41431-024-01549-3
U2 - 10.1038/s41431-024-01549-3
DO - 10.1038/s41431-024-01549-3
M3 - Article
C2 - 38355962
JO - European journal of human genetics : EJHG
JF - European journal of human genetics : EJHG
ER -